UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000001051
Receipt number R000001261
Scientific Title COMPARISON OF PREGNANCY OUTCOME IN OOCYTE RECIPIENTS AFTER GNRH ANTAGONIST TREATMENT IN THE PROLIPHERATIVE PHASE
Date of disclosure of the study information 2008/02/25
Last modified on 2008/02/29 20:19:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

COMPARISON OF PREGNANCY OUTCOME IN OOCYTE RECIPIENTS AFTER GNRH ANTAGONIST TREATMENT IN THE PROLIPHERATIVE PHASE

Acronym

PREGNANCY RATES AFTER GNRH ANTAGONIST ADMINISTRATION

Scientific Title

COMPARISON OF PREGNANCY OUTCOME IN OOCYTE RECIPIENTS AFTER GNRH ANTAGONIST TREATMENT IN THE PROLIPHERATIVE PHASE

Scientific Title:Acronym

PREGNANCY RATES AFTER GNRH ANTAGONIST ADMINISTRATION

Region

Europe


Condition

Condition

IN VITRO FERTILIZATION CYCLES

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

INVESTIGATE THE EFFECT OF GNRH ANTAGONISTS ON PREGNANCY OUTCOME

Basic objectives2

Others

Basic objectives -Others

EFFECT ON CLINICAL OUTCOME

Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase IV


Assessment

Primary outcomes

PREGNANCY RATES

Key secondary outcomes

IMPLANTATION RATES, MISCARRIAGE RATES, ENDOMETRIAL THICKNESS


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -investigator(s) and assessor(s) are blinded

Control

No treatment

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

TREATMENT WITH GNRH ANTAGONIST

Interventions/Control_2

NO TREATMENT

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

50 years-old >=

Gender

Female

Key inclusion criteria

MENOPAUSAL WOMEN, AT LEAST 6 OOCYTES FROM THE DONOR TO PROCEED WITH IVF CYCLES

Key exclusion criteria

THREE PREVIOUS FAILED ivf CYCLES, UTERINE MALFORMATION,

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name NIKOS PRAPAS

Organization

IAKENTRO FERTILITY CENTRE/ 4TH DEP OBS AND GYNAE-IPPOKRATION GEN HOSPITAL

Division name

PRVIVATE FERTILITY CENTRE

Zip code


Address

AG VASILIOU 4 STR/ 54250 THESSALONIKI/GREECE

TEL

+302310325525

Email



Public contact

Name of contact person

1st name
Middle name
Last name ASIMINA TAVANIOTOU

Organization

IAKENTRO FERTILITY CENTRE

Division name

PRIVATE FERTILITY CENTRE

Zip code


Address

AG VASILIOU 4 STR/ 54250 THESSALONIKI GREECE

TEL

+302310325525

Homepage URL


Email

mtavaniotou@hotmail.com


Sponsor or person

Institute

IAKENTRO FERTILITY CENTRE

Institute

Department

Personal name



Funding Source

Organization

SELF FUNDING

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2008 Year 02 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

NO DIFFERENCE IN PREGNANCY RATES BETWEEN THE TWO GROUPS

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2004 Year 05 Month 01 Day

Date of IRB


Anticipated trial start date

2004 Year 05 Month 01 Day

Last follow-up date

2006 Year 05 Month 01 Day

Date of closure to data entry

2006 Year 05 Month 01 Day

Date trial data considered complete

2006 Year 05 Month 01 Day

Date analysis concluded

2008 Year 02 Month 01 Day


Other

Other related information



Management information

Registered date

2008 Year 02 Month 25 Day

Last modified on

2008 Year 02 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001261


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name